Novo Nordisk A/S (NVO) Will Double Revenue Within A Decade: Deputy CEO
6/25/2014 8:35:04 AM
(Reuters) - Danish drugmaker Novo Nordisk, the world's biggest insulin maker, expects to more than double its annual revenue within a decade, its deputy chief executive Kaare Schultz told Reuters.
More than half a billion people are expected to be living with diabetes by 2035, up from 382 million now, according to the International Diabetes Federation. Most sufferers have type 2 diabetes - linked to obesity and lack of exercise - and the epidemic is spreading as more people in the developing world adopt Western, urban lifestyles.
Help employers find you! Check out all the jobs and post your resume.
comments powered by